Financials
Financial year 2025
FARAJ PHARMA from Sint-Gillis (bij-Brussel), company number BE0657789662, closed financial year 2025 with a result of € 31,332 after tax. For that financial year FARAJ PHARMA recorded a gross margin of € 44,273 and equity of € 47,642. Compared with financial year 2024, the result moved from € 29,348 to € 31,332. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on March 30, 2026.
€ 47,642
▲ 81% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 31,332
▲ 7% vs 2024
Profit after tax over the fiscal year.
€ 56,609
▲ 23% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 10,000 paid out
32 % of the profit went to the shareholders, the rest stayed in the company.
People and assets in 2025
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 703
▼ 65% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 38,888
▼ 6% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 923
▼ 76% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 38,717 | € 37,114 | € 43,184 | € 44,273 | ▲ 3% |
| Profit after taxes | € 21,655 | € 19,487 | € 29,348 | € 31,332 | ▲ 7% |
| Equity | € 10,075 | € 41,962 | € 26,310 | € 47,642 | ▲ 81% |
| Total debts | € 110,504 | € 71,723 | € 90,377 | € 81,163 | ▼ 10% |
| Cash | € 48,468 | € 42,879 | € 46,010 | € 56,609 | ▲ 23% |
| Retained profit | € 3,875 | € 23,362 | € 7,710 | € 29,042 | ▲ 277% |
| Dividend | € 20,000 | € 0 | € 45,000 | € 10,000 | ▼ 78% |
| Bank debt | € 11,531 | € 0 | € 0 | € 0 | |
| Balance sheet total | € 120,579 | € 113,685 | € 116,686 | € 128,805 | ▲ 10% |
Key figures of FARAJ PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to FARAJ PHARMA?
What happened at FARAJ PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 31,332 (▲ 7% vs 2024). Source: NBB ↗
- New establishment in Sint-Gillis (bij-Brussel). KBO
- ABDELLAH EL BAYAD became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 21,655 profit in 2022 to € 31,332 profit in 2025.
Paid € 31,658 in corporate taxes since 2022.
Best year ever: 2025, with € 31,332 profit.
Paid out € 75,000 in dividends to the owners in total.
Management
Behind FARAJ PHARMA is ABDELLAH EL BAYAD.
Directors
According to the 2025 annual accounts
ABDELLAH EL BAYAD
Director
since 2016
Establishments
Establishment units
Physical locations of this company
Vorstse Steenweg 214
1060 Sint-Gillis (bij-Brussel)
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0657.789.662
- VAT number
- BE 0657.789.662
- Registered office
- Vorstse Steenweg 214, 1060 Sint-Gillis (bij-Brussel)
- Names & denominations
- FARAJ PHARMA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 June 2016
- Peppol
- Active · Active since 26 Nov 2025
- Activities · NACE
Activiteiten van holdings
Holdings
Detailhandel in farmaceutische producten
Activiteiten van adviesbureaus op het gebied van public relations en communicatie
Adviesbureaus op het gebied van public relations en communicatie